S

Active Director Director DIN 08288799
DIN 08288799 First appointment Nov 2018 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value •••• Premium profile

About Satybhama

Data last updated:

Satybhama is a Director at Bhanurays Pharma Private Limited (since 2018). The company operates in Business Services. Bhanurays Pharma Private Limited reported revenue of ₹29,140 (FY 2023).

DIN 08288799
Primary Designation Director
Industry Business Services
First Appointment 28 Nov 2018
Oldest Company Age 7 yrs
Largest company Bhanurays Pharma Private Limited · ₹29,140 (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bhanurays Pharma Private Limited U74999UP2018PTC110661
Director28 Nov 20182018₹29,140 (FY 2023)Active

Board colleagues of Satybhama

NameDINCompanyDesignation
Bali Ram Yadav08288798Bhanurays Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bhanurays Pharma Private Limited
Premium access

Shareholding and investment profile for Satybhama

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satybhama

Satybhama currently holds 1 directorship: Bhanurays Pharma Private Limited (Director, since 28 Nov 2018, revenue ₹29,140 (FY 2023)).

Satybhama was first appointed on 28 Nov 2018 as Director at Bhanurays Pharma Private Limited.

The current boards of Satybhama's companies include Bali Ram Yadav (Bhanurays Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available